I find this hilarious! Although i'm sure they will continue to try to pull the stock back down at any opportunity, the momentum here should be obvious. And the great thing is, as more and data come out, the revenue estimates will go up and up and up, IMO. I think there has been enough data on Adcetris to have some confidence in the results in the ongoing trials, as the data has so far been fairly consistent.
This is not even giving any consideration to potential positive results in other drugs in the pipeline!